Notwithstanding having the ‘best of vaccines’, the USA is on the verge of giving a green signal to another vaccine soon to tame the ever-changing variants of SARS-CoV2, including Omicron; whereas the ‘Made in India’ vaccines like Covaxin and Covishield seem to have taken a better grip of mutating Covid-19 virus in India.As per Pfizer…Continue Reading
Indian biotech firm Bharat Biotech on Saturday claimed that its Covid vaccine, Covaxin, offered long-term protection against severe Covid disease when used as a booster dose during the clinical trial. The Hyderabad-based company said it found encouraging results after a booster dose was given to trial participants six months from the day they received their second…Continue Reading
Curated by अमित शुक्ला | नवभारतटाइम्स.कॉम | Updated: Dec 30, 2021, 8:01 PMकोवैक्सीन के 2-18 साल के बच्चों पर किए गए दूसरे और तीसरे चरण के अध्ययन के नतीजे उत्साहजनक है। भारत बायोटेक का दावा है कि यह पूरी तरह सेफ है। साथ ही यह बड़ों के मुकाबले बच्चों को ज्यादा सुरक्षा प्रदान करती है।…Continue Reading
Hyderabad-based vaccine maker Bharat Biotech received a shot in the arm Wednesday as the World Health Organisation (WHO) granted approval to India’s first indigenous Covid vaccine– Covaxin– for emergency use listing (EUL). The WHO clearance is a significant step in Covaxin being accepted by foreign governments. It will remove uncertainty around overseas travel by Indians inoculated…Continue Reading
You don’t have permission to access “http://indiatoday.intoday.in/programme/5ive-live/video/covaxin-gets-emergency-use-nod-for-children-aged-2-18-years-crackdown-on-terror-nia-raids-16-places-in-j-k-more-1864027-2021-10-12” on this server. Reference #18.41243017.1634170491.8298fa4bContinue Reading
Experts noted that two doses of Covaxin could be administered to children within a gap of 28 days Representational photo. Experts noted that two doses of Covaxin could be administered to children within a gap of 28 days The Subject Expert Committee (SEC) of the Central Drugs Standards Control Organisation (CDSCO) has submitted its…Continue Reading
The Subject Expert Committee (SEC) has given a recommendation to DCGI (Drugs Controller General of India) for the use of BharatBiotech’s Covid-19 vaccine Covaxin for 2-18 year olds on Tuesday, as per official sources. Back in August, India had also granted emergency use approval to ZyCov-D’s Covid-19 vaccine for children between the ages of 12…Continue Reading
Subject Expert Committee has approved Bharat Biotech’s covid vaccine ‘COVAXIN’ for children in the 2-18 age group. DCGI will now to take the final call. As part of the Phase II/III trial, the two-dose Covaxin was administered to 525 children 28 days apart. Bharat Biotech had received the drug regulators’ nod to conduct the children’s…Continue Reading